home / stock / lyra / lyra news

LYRA News and Press, Lyra Therapeutics Inc.

Stock Information
Company Name: Lyra Therapeutics Inc.
Stock Symbol: LYRA
Market: NASDAQ
Website: lyratherapeutics.com
Menu
LYRA LYRA Quote LYRA Short LYRA News LYRA Articles LYRA Message Board
Get LYRA Alerts

News, Short Squeeze, Breakout and More Instantly...
LYRA - Pricey healthcare stocks with halting momentum - low momentum and high valuation

2026-02-03 14:23:14 ET More on AIM ImmunoTech, State Street Health Care Select Sector SPDR ETF, etc. CMS Rates Proposal Shatters Health Insurance Stocks: What Investors Must Know (& Do) Insurers Brace For Extended 'Managed Retreat' Following 2027 MA Proposal XLV ...
LYRA - US Companies Moving the Markets, Morning edition
Tue, Jan 13, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Envirotech Vehicles Inc. (EVTV) rose 442.0% to $2.51 on volume of 760,991,766 shares Oriental Culture Holding LTD (OCG) fell 15.5% to $0.0169 on volume of 452,241,771 shares Mingteng International Corporation Inc. (MTEN) fell 41.9% to $...

LYRA - US Companies Moving the Markets, Evening edition
Mon, Jan 12, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Envirotech Vehicles Inc. (EVTV) rose 295.2% to $1.83 on volume of 610,320,780 shares Oriental Culture Holding LTD (OCG) fell 15.0% to $0.017 on volume of 389,655,949 shares Mingteng International Corporation Inc. (MTEN) fell 43.7% to $0...

LYRA - Lyra Therapeutics Provides Corporate Update

WATERTOWN, Mass., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”) today announced that its Board of Directors has decided to suspend further development of LYR-210, the Company’s lead product candidate for the t...
LYRA - Lyra Therapeutics Inc. (NASDAQ: LYRA) Rises Sharply in 12/15 Early Trading Session

2025-12-15 10:36:41 ET Lyra Therapeutics, Inc. (NASDAQ: LYRA) is one of today’s top gainers. The company’s shares have moved 8.54% on the day to $3.94. Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of ...

LYRA - Lyra Therapeutics Inc. (NASDAQ: LYRA) Rises Sharply in 11/26 Early Trading Session

2025-11-26 12:17:23 ET Lyra Therapeutics, Inc. (NASDAQ: LYRA) is one of today’s top gainers. The company’s shares have moved 20.68% on the day to $3.48. Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of...

LYRA - Lyra Therapeutics GAAP EPS of -$3.38 beats by $0.98

2025-11-13 00:53:06 ET More on Lyra Therapeutics Seeking Alpha’s Quant Rating on Lyra Therapeutics Historical earnings data for Lyra Therapeutics Financial information for Lyra Therapeutics Read the full article on Seeking Alpha For further det...
LYRA - Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update

– Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission – WATERTOWN, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics , Inc. (Nasdaq: LYRA) (“L...

LYRA - Expected US Company Earnings on Tuesday, November 11th, 2025

Ensysce Biosciences Inc. (ENSC) is expected to report $-0.85 for Q3 2025 IO Biotech Inc. (IOBT) is expected to report $-0.31 for Q3 2025 Lifeward Ltd. (LFWD) is expected to report $-0.14 for Q3 2025 Life360 Inc. (LIF) is expected to report $0.03 for Q3 2025 Pixelworks Inc. (PXLW) ...

LYRA - Lyra Therapeutics Announces Clinical Plan for LYR-210 and Late-Breaking Oral Presentation of Phase 3 ENLIGHTEN 2 Study

Company outlines clinical plan for LYR-210 based on FDA meeting on the path to NDA submission Positive ENLIGHTEN 2 results highlighted at the AAO-HNS 2025 Annual Meeting WATERTOWN, Mass., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), (“Lyra...
Next 10